Template:SupbiotechparisFr
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) |
Enguerrand (Talk | contribs) |
||
Line 65: | Line 65: | ||
*[[Team:SupBiotech-Paris/Thérapies actuelles|Thérapies actuelles]] | *[[Team:SupBiotech-Paris/Thérapies actuelles|Thérapies actuelles]] | ||
*[[Team:SupBiotech-Paris/Thérapies géniques|Thérapies géniques]] | *[[Team:SupBiotech-Paris/Thérapies géniques|Thérapies géniques]] | ||
+ | </div> | ||
<span style="color: gold;">'''1er Constat'''</span><br> | <span style="color: gold;">'''1er Constat'''</span><br> | ||
Line 71: | Line 72: | ||
*[[Team:SupBiotech-Paris/Concept1Fr|Concept]] | *[[Team:SupBiotech-Paris/Concept1Fr|Concept]] | ||
*[[Team:SupBiotech-Paris/Conclusion1Fr|Conclusion]] | *[[Team:SupBiotech-Paris/Conclusion1Fr|Conclusion]] | ||
+ | </div> | ||
<span style="color: gold;">'''2nd Constat'''</span><br> | <span style="color: gold;">'''2nd Constat'''</span><br> | ||
Line 77: | Line 79: | ||
*[[Team:SupBiotech-Paris/Concept2Fr|Concept]] | *[[Team:SupBiotech-Paris/Concept2Fr|Concept]] | ||
*[[Team:SupBiotech-Paris/Conclusion2Fr|Conclusion]] | *[[Team:SupBiotech-Paris/Conclusion2Fr|Conclusion]] | ||
+ | </div> | ||
<span style="color: gold;">'''Mise en application'''</span><br> | <span style="color: gold;">'''Mise en application'''</span><br> |
Revision as of 17:12, 29 August 2009